Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel ... ( ROCKVILLE Md. Sept. 2 /- Human Ge...)

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Conference

Date:9/2/2008

ROCKVILLE, Md., Sept. 2 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that its presentation at the 2008 Thomas Weisel Partners Annual Healthcare Conference will be webcast and may be accessed at http://www.hgsi.com.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

A member of Human Genome Sciences' senior management team will present a corporate overview on Thursday, September 4, 2008 at 8:35 am Eastern Time.

Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

HGS and Human Genome Sciences are registered trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the company's web site at http://www.hgsi.com.

0

GOOD

Page: 1
Related biology technology :

1. Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
2. UC Riverside researcher develops novel method to grow human embryonic stem cells
3. ArunA Biomedical Announces Exclusive Worldwide Technology Licensing Agreement to Commercialize Human Embryonic Stem Cell Derived Mesenchymal Cells
4. DSM Biologics and MorphoSys AG to Manufacture Fully Human Antibody
5. Thousands Rally in Mexico City and Call for Human Rights Protections in Global AIDS Response
6. Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments
7. Human Genome Sciences Appoints David P. Southwell to its Board of Directors
8. Human Genome Sciences to Sponsor Conference Call to Discuss Second Quarter 2008 Financial Results
9. New map IDs the core of the human brain
10. BioTime, Inc. and Embryome Sciences, Inc. Sign Agreement With International Stem Cell Corporation to Provide Unique Human Stem Cell Lines for Research Use
11. Aegera Therapeutics collaboration with Human Genome Sciences leads to the initiation of a Phase 1 clinical trial with lead IAP inhibitor HGS1029 and receipt of first milestone payment

Post Your Comments:

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel ...( ROCKVILLE Md. Sept. 2 /- Human Ge...)